Announcement: Intentional Spaces Roadmap
Johns Hopkins’ International Arts + Mind Lab Releases the Intentional Spaces Roadmap, an Evidence-Based Strategy for Designing Environments that Support Health and Wellbeing
Report: Realizing the Potential of the Science Community to Support Rising Generations in STEM
This report, developed as part of the Aspen Institute Science & Society Program’s 2025 roundtable series, synthesizes insights from practitioners in K–12 education, higher education, science research, professional associations, science communication, and civic science. The project builds on Science & Society’s long-standing informal science education work, including the award-winning Our Future Is Science (OFIS) youth initiative.
Realizing the Potential of the Science Community to Support Rising Generations in STEM
A recent report by the Science & Society Program discusses fundamental questions about recent and rapid policy shifts within the federally-funded research and higher education ecosystems, as well as our our nation’s social contract for science, originally articulated in 1945 through Vannevar Bush’s groundbreaking Endless Frontier report.
Press Release: NeuroArts Blueprint Initiative Launches Nationwide Network of Community Neuroarts Coalitions
NeuroArts Blueprint
On November 12, the NeuroArts Blueprint Initiative launched the Community Neuroarts Coalitions (CNC) Network to support 11 communities across the U.S. using the power of the arts to improve health and well-being. Each CNC will create evidence-to-impact collaborations among local partners to translate the science of neuroarts into practical programs that enhance the health, well-being, cohesion, and resilience of their communities.
News Article: Medicare Can’t Afford Not To Cover Ozempic
A decision for whether Medicare will cover a revolutionary new class of weight-loss treatments, which include drugs like Zepbound and Wegovy, could be imminent, according to Dr. Mehmet Oz, head of the Centers for Medicare and Medicaid Services.
News Article: CMS Administrator Dr. Oz on GLP-1 for weight loss in Medicare: You’ll be hearing more soon
CMS Administrator Dr. Mehmet Oz addressed the rising discussion around covering GLP-1 medications (like Ozempic and Wegovy) for weight loss under Medicare. Citing “a lot of action” in the space, Oz confirmed that a decision on whether to expand coverage for these high-cost treatments is imminent. Read or watch the video to hear his full comments on the future of this policy.
